These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29366517)

  • 21. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.
    Hamza RT; Elfaramawy AA; Mahmoud NH
    Horm Res Paediatr; 2016; 86(1):11-20. PubMed ID: 27309736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 May; 14(5):726. PubMed ID: 29576483
    [No Abstract]   [Full Text] [Related]  

  • 25. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.
    Shi L; Liu ZW; Li Y; Gong C; Zhang H; Song LJ; Huang CY; Li M
    Biomed Environ Sci; 2012 Aug; 25(4):383-91. PubMed ID: 23026517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits.
    Eshraghian A
    Hepatology; 2017 Mar; 65(3):1077. PubMed ID: 27859430
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet.
    Félix DR; Costenaro F; Gottschall CB; Coral GP
    BMC Pediatr; 2016 Nov; 16(1):187. PubMed ID: 27846831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease.
    Pimentel CF; Lai M
    Med Clin North Am; 2016 Nov; 100(6):1303-1327. PubMed ID: 27745596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obese children with fatty liver: Between reality and disease mongering.
    Ranucci G; Spagnuolo MI; Iorio R
    World J Gastroenterol; 2017 Dec; 23(47):8277-8282. PubMed ID: 29307987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonobese Fatty Liver Disease.
    Kim D; Kim WR
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):474-485. PubMed ID: 27581063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H
    Can J Cardiol; 2013 Sep; 29(9):1139.e9. PubMed ID: 23352427
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].
    Gillessen A
    MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
    Carrieri P; Duracinsky M; Marcellin F; Lazarus JV
    Hepatology; 2019 Jul; 70(1):443-444. PubMed ID: 30472796
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
    J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nonalcoholic Fatty Liver Disease and Weight Loss].
    Ping F; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Oct; 40(5):597-602. PubMed ID: 30404689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.